These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 7448414

  • 21. Biochemical and biophysical conditions for blood clot lysis.
    Šabovič M, Blinc A.
    Pflugers Arch; 2000 Jan; 440(Suppl 1):R134-R136. PubMed ID: 28008511
    [Abstract] [Full Text] [Related]

  • 22. Enhancing effect of platelets on staphylokinase-mediated clot lysis and plasminogen activation.
    Suehiro A, Tsujioka H, Yoshimoto H, Ueda M, Higasa S, Kakishita E.
    Thromb Res; 1995 Oct 15; 80(2):135-42. PubMed ID: 8588190
    [Abstract] [Full Text] [Related]

  • 23. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L, Noser D, Larsen JB, Dobó J, Gál P, Pál G, Schroeder V.
    Mol Immunol; 2019 Oct 15; 114():1-9. PubMed ID: 31325724
    [Abstract] [Full Text] [Related]

  • 24. Asymmetrical Forces Dictate the Distribution and Morphology of Platelets in Blood Clots.
    Kovalenko TA, Giraud MN, Eckly A, Ribba AS, Proamer F, Fraboulet S, Podoplelova NA, Valentin J, Panteleev MA, Gonelle-Gispert C, Cook S, Lafanechère L, Sveshnikova AN, Sadoul K.
    Cells; 2021 Mar 06; 10(3):. PubMed ID: 33800866
    [Abstract] [Full Text] [Related]

  • 25. [Correlation between thrombocytes and fibrinolysis].
    Udvardy M, Pósán E, Rák K.
    Orv Hetil; 1994 Mar 27; 135(13):677-80. PubMed ID: 8170667
    [Abstract] [Full Text] [Related]

  • 26. Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.
    Rusak T, Piszcz J, Misztal T, Brańska-Januszewska J, Tomasiak M.
    Thromb Res; 2014 Jul 27; 134(1):192-8. PubMed ID: 24824295
    [Abstract] [Full Text] [Related]

  • 27. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
    Braaten JV, Jerome WG, Hantgan RR.
    Blood; 1994 Feb 15; 83(4):982-93. PubMed ID: 8111066
    [Abstract] [Full Text] [Related]

  • 28. Endogenous fibrinolysis facilitates clot retraction in vivo.
    Samson AL, Alwis I, Maclean JAA, Priyananda P, Hawkett B, Schoenwaelder SM, Jackson SP.
    Blood; 2017 Dec 07; 130(23):2453-2462. PubMed ID: 29074499
    [Abstract] [Full Text] [Related]

  • 29. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R, Mirshahi S, Mirshahi P, Klein C, Jamshedov J, Chidiac J, Perzborn E, Mirshahi M, Soria C, Soria J.
    Thromb Res; 2013 Mar 07; 131(3):e100-9. PubMed ID: 23313382
    [Abstract] [Full Text] [Related]

  • 30. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma.
    Carr ME, Zekert SL.
    Am J Physiol; 1994 Mar 07; 266(3 Pt 2):H1195-201. PubMed ID: 8160823
    [Abstract] [Full Text] [Related]

  • 31. Fibrin network structure: modification by platelets.
    Dhall TZ, Shah GA, Ferguson IA, Dhall DP.
    Thromb Haemost; 1983 Feb 28; 49(1):42-6. PubMed ID: 6845271
    [Abstract] [Full Text] [Related]

  • 32. Plasminogen activation and lysis of blood clots induced by cells in vitro.
    Knox P, Crooks S.
    J Cell Physiol; 1988 Jun 28; 135(3):467-73. PubMed ID: 2456288
    [Abstract] [Full Text] [Related]

  • 33. The role of platelets and leukocytes in coagulation and fibrinolysis.
    Cucuianu M, Trif I.
    Rev Roum Physiol (1990); 1992 Jun 28; 29(1-2):33-8. PubMed ID: 1472550
    [Abstract] [Full Text] [Related]

  • 34. Integration of clotting and fibrinolysis: central role of platelets and factor XIIIa.
    Patalakh I, Revka O, Gołaszewska A, Bielicka N, Misztal T.
    Biosci Rep; 2024 Sep 25; 44(9):. PubMed ID: 39212493
    [Abstract] [Full Text] [Related]

  • 35. The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography.
    Katori N, Tanaka KA, Szlam F, Levy JH.
    Anesth Analg; 2005 Jun 25; 100(6):1781-1785. PubMed ID: 15920213
    [Abstract] [Full Text] [Related]

  • 36. Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia.
    Pósán E, Ujj G, Kiss A, Telek B, Rák K, Udvardy M.
    Thromb Res; 1998 Apr 15; 90(2):51-6. PubMed ID: 9684757
    [Abstract] [Full Text] [Related]

  • 37. Peroxynitrite--altered platelet mitochondria--a new link between inflammation and hemostasis.
    Misztal T, Przesław K, Rusak T, Tomasiak M.
    Thromb Res; 2013 Jan 15; 131(1):e17-25. PubMed ID: 23200902
    [Abstract] [Full Text] [Related]

  • 38. Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties.
    Bryk AH, Natorska J, Ząbczyk M, Zettl K, Wiśniewski JR, Undas A.
    J Proteomics; 2020 Oct 30; 229():103946. PubMed ID: 32810596
    [Abstract] [Full Text] [Related]

  • 39. A novel, quantitative clot retraction assay to evaluate platelet function.
    Muraoka WT, Nair PM, Darlington DN, Wu X, Bynum JA, Cap AP.
    Platelets; 2023 Dec 30; 34(1):2254403. PubMed ID: 37700390
    [Abstract] [Full Text] [Related]

  • 40. Phase transitions during compression and decompression of clots from platelet-poor plasma, platelet-rich plasma and whole blood.
    Liang X, Chernysh I, Purohit PK, Weisel JW.
    Acta Biomater; 2017 Sep 15; 60():275-290. PubMed ID: 28694237
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.